Hepatitis C infection increases lymphoma risk

Michael Carter
Published: 09 May 2007

Infection with hepatitis C virus significantly increases the risk of developing certain lymphomas (cancer of the lymphatic system), according to a US study published in the May 8th edition of the Journal of the American Medical Association.

Investigators speculated that hepatitis C virus, which can cause liver cirrhosis and liver cancer, may also be associated with an increased risk of haematologic malignancies, lymphatic cancer, and cancer of the thyroid. They therefore performed a retrospective analysis of the records of 700,000 individuals who received care from Veterans’ Affairs hospitals between 1996 and 2004.

A total of 146,394 of these individuals were infected with hepatitis C. Patients with hepatitis C were matched with up to four uninfected individuals of the same sex, age, and first date of follow-up visit. In the days before potent anti-HIV therapy became available, non-Hodgkin’s lymphoma was often seen in HIV-infected individuals with very low CD4 cell counts, and it remains an AIDS-defining cancer, although it has become much rarer thanks to effective HIV treatment. Nevertheless, because of the malignancy’s association with HIV infection, HIV-positive individuals were excluded from the study.

The mean age of the study population was 52 years, and 97% were men. Individuals infected with hepatitis C virus were no more likely to have haematological malignancies than uninfected individuals.

However, the investigators did find that infection with hepatitis C virus increased the risk of non-Hodgkin’s lymphoma by 28% (adjusted hazard ratio [HR], 1.28, confidence interval [CI]: 1.12-1.45). They also found that, compared to individuals without hepatitis C, patients with hepatitis C had a significantly increased risk of a very rare form of non-Hodgkin’s lymphoma, Waldenström macroglobulinemia (adjusted HR, 2.76; 95% CI, 2.01-3.79), and of a blood disorder often associated with hepatitis C virus called cryoglobulinaemia (adjusted HR, 3.98; 95% CI, 3.36-4.72).

Although hepatitis C-infected individuals had an increased risk of thyroid problems, they did not have an increased risk of thyroid cancer.

In multivariate analysis, the association between non-Hodgkin’s lymphoma, Waldenström macroglobulinemia, cryoglobulinemia, and thyroiditis remained statistically significant (p = 0.038).

"Although the risk of developing lymphomas is small, our research suggests that screening of HCV-infected individuals could identify conditions which may lead to cancer. It might then be possible to prevent progression to lymphoma," commented investigator Eric A. Engels, adding, "more research is needed to further clarify the relationship between HCV infection and lymphoma."

Reference

Giordano TP et al. Risk of non-Hodgkin lymphoma and lymphoproliferate precursor diseases in US veterans with hepatitis C virus. Journal of the American Medical Association 297: 2010 – 2017, 2007.

Hepatitis information

For more information on hepatitis visit infohep.org.

Infohep is a project we're working on with the World Hepatitis Alliance and the European Liver Patients Association.

Visit infohep.org >

Related news selected from other sources

More editors' picks on hepatitis and HIV >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.